Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Recap: Arrowhead Pharmaceuticals Q1 Earnings

 

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported its Q1 earnings results on Wednesday, February 2, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Also check out: Insiders Buying Pixelworks And 4 Other Penny Stocks

Earnings

Arrowhead Pharmaceuticals missed estimated earnings by 33.33%, reporting an EPS of $-0.6 versus an estimate of $-0.45, which surprised analysts.

Revenue was up $6.14 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.51, which was followed by a 2.32% increase in the share price the next day.

Here's a look at Arrowhead Pharmaceuticals's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.10 -0.20 -0.13 0.17
EPS Actual -0.61 -0.29 -0.26 -0.20
Revenue Estimate 56.77M 37.52M 37.70M 86.69M
Revenue Actual 38.28M 45.89M 32.81M 21.30M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.